Back
Molecular Partners AG Vs. NLS Pharmaceutics Industry Stock Comparison
Sell
38
MOLN
Molecular Partners AG
Last Price:
5.00
Seasonality Move:
-13.18%
Sell
30
NLSP
NLS Pharmaceutics
Last Price:
0.14
Seasonality Move:
-35.67%
Sell
38
Molecular Partners AG (MOLN)
is a Sell
Is Molecular Partners AG a Buy, Sell or Hold?
- The current Molecular Partners AG [MOLN] share price is $5.08. The Score for MOLN is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- MOLN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
NLS Pharmaceutics (NLSP)
is a Sell
Is NLS Pharmaceutics a Buy, Sell or Hold?
- The current NLS Pharmaceutics [NLSP] share price is $0.14. The Score for NLSP is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- NLSP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MOLN Stock Price Chart
What is Molecular Partners AG's stock price today?
-
The Molecular Partners AG share price today is $5.08
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MOLN is experiencing selling pressure, which indicates risk of future bearish movement.
NLSP Stock Price Chart
What is NLS Pharmaceutics's stock price today?
-
The NLS Pharmaceutics share price today is $0.14
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NLSP is experiencing buying pressure, which is a positive indicator for future bullish movement.
MOLN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.32 | Sell |
| Relative Strength Index (14 RSI): | 36.67 | Sell |
| Chaikin Money Flow: | -1754 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.48 - 6.5) | Sell |
| Bollinger Bands (100): | (4.18 - 7.12) | Sell |
NLSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 41.35 | Sell |
| Chaikin Money Flow: | 175485 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.14 - 0.18) | Sell |
| Bollinger Bands (100): | (0.14 - 0.2) | Sell |
MOLN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.38 | Sell |
| 20-day SMA: | 5.88 | Sell |
| 50-day SMA: | 6.26 | Sell |
| 200-day SMA: | 4.97 | Buy |
| 8-day EMA: | 5.4 | Sell |
| 20-day EMA: | 5.74 | Sell |
| 50-day EMA: | 5.98 | Sell |
| 200-day EMA: | 5.45 | Sell |
NLSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.13 | Buy |
| 20-day SMA: | 0.15 | Sell |
| 50-day SMA: | 0.18 | Sell |
| 200-day SMA: | 0.27 | Sell |
| 8-day EMA: | 0.14 | Buy |
| 20-day EMA: | 0.15 | Sell |
| 50-day EMA: | 0.17 | Sell |
| 200-day EMA: | 0.31 | Sell |
Molecular Partners AG Earnings Growth & MOLN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and a decrease next year of $0.19 per share.
NLS Pharmaceutics Earnings Growth & NLSP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Molecular Partners AG Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NLS Pharmaceutics Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||